NCT06410079

Brief Summary

This study aims to evaluate the return to activity in younger patients under 50 years old after undergoing either total hip replacement (THR) or hip resurfacing, as performed in everyday practice. This research will be observational, meaning patients will not be randomly assigned to different treatment groups. To objectively assess participents; return to everyday, professional, and sports activities, validated questionnaires will be sent to participents in addition to routine clinical practice. The study will be prospective and comparative based on the type of prostheses used. In order to capture the current practices of surgeons performing THR in participents under 50 years old in France, the study will be conducted at multiple centers across the country. Since hip resurfacing is performed only in certain centers, approximately half of the participating centers are experienced in this technique. Participents typically resume activity between 3 and 6 months after THR. One year of post-operative follow-up allows for an accurate assessment of participents; recovery, unaffected by the surgery. Participents ; physical activity levels will be evaluated using the UCLA Activity Scale developed by surgeons to assess the activity levels of patients undergoing hip and arthroplasty.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
4mo left

Started Jun 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Jun 2024Sep 2026

First Submitted

Initial submission to the registry

May 3, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 10, 2024

Completed
22 days until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 8, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 8, 2026

Expected
Last Updated

May 10, 2024

Status Verified

May 1, 2024

Enrollment Period

1.8 years

First QC Date

May 3, 2024

Last Update Submit

May 8, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • UCLA hip score

    The UCLA Hip Score is a validated measurement tool used to assess the level of physical activity in patients undergoing hip arthroplasty. It consists of a single-item scale ranging from 10 to 1. A score of 10 indicates regular participation in impact sports, while a score of 1 indicates complete inactivity and dependency on others. This score is utilized to evaluate the patient's functional outcome and activity level following hip surgery.

    Day 0, and 3 ,6,12 mounths

Secondary Outcomes (10)

  • Subjective Hip Value (SHV) Score

    Days 14 and 3,6, 12 mounths

  • The Forgotten Joint Score (FJS)

    Day 0, and 3 ,6,12 mounths

  • Oxford Hip Score (OHS)

    Day 0, and 3 ,6,12 mounths

  • The DEVANE Score

    Day 0, 12 mounths

  • Age

    Day 0

  • +5 more secondary outcomes

Study Arms (2)

resurfacing

involves removing damaged cartilage and bone from the hip joint, half of the femoral head is cut, the neck and the other half are preserved, the acetabulum is covered by a metal cup

Procedure: total hip replacement

total hip prosthesis

dual mobility total hip prosthesis in polyethylene, ceramic hip prosthesis, total hip prosthesis in ceramic or metal and polyethylene

Procedure: total hip replacement

Interventions

Replacement of the hip joint with a total prosthesis, a femoral stem, an acetabular cup, a joint head, in metal, ceramic, dual mobility or polyethylene

resurfacingtotal hip prosthesis

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Patients will be recruited by surgeons during orthopedic surgery consultations at each of the participating centers in the study. These consultations will take place between 3 and 1 month before the intervention. The purpose of the research will be explained to all patients who meet the eligibility criteria by the surgeon and an information sheet will be given to them. The physician will obtain the patients consent to participate in the research and their non-opposition to the collection and use of their data at least 14 days before the intervention, allowing sufficient time for the participant to reflect.

You may qualify if:

  • Participant is male or female, aged 50 or under
  • Participant is indicated for a primary THA or resurfacing procedure
  • Participant agrees to complete and receive questionnaires by email
  • Participant has been informed and has not objected to the collection and use of their data

You may not qualify if:

  • Participant is aged under 18 or over 50 years
  • Participant has had a previous THA or resurfacing procedure
  • Participant is scheduled for a THA on the other hip within the year
  • Participant has severe physical and/or psychological health problems that, in the investigators opinion, may affect the participant\'s compliance with the study
  • Participant is participating in another research study
  • Participant is a protected person: an adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
  • Participant is pregnant, breastfeeding or giving birth
  • Participant is hospitalized without consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Santé Atlantique

Saint-Herblain, Nantes, 44800, France

Location

Related Links

MeSH Terms

Conditions

Osteoarthritis, HipFemur Head Necrosis

Interventions

Arthroplasty, Replacement, Hip

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesOsteonecrosisBone DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • Ronald Isida, MD

    SFHG

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jean Marie PHILIPPEAU, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 3, 2024

First Posted

May 10, 2024

Study Start

June 1, 2024

Primary Completion

March 8, 2026

Study Completion (Estimated)

September 8, 2026

Last Updated

May 10, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

the sponsor has not yet decided on the sharing, a meeting of all members of the association must take place soon to decide

Locations